GGrantIndex
← Search

CLINICAL RESEARCH

$157,506P30FY2002CANIH

Sloan-Kettering Institute For Cancer Res, New York NY

Investigators

Linked publications, trials & patents

Trial NCT03699631Trial NCT02595918Trial NCT02417701Trial NCT02219737Trial NCT02152995Trial NCT01979523Trial NCT01947023Trial NCT01902160Trial NCT01705340Trial NCT01643278Trial NCT01638546Trial NCT01587352Trial NCT01585805Trial NCT01326702Trial NCT01281865Trial NCT01196416Trial NCT01154452Trial NCT01143402Trial NCT01119599Trial NCT01051557Trial NCT01026623Trial NCT01016015Trial NCT00957905Trial NCT00866177Trial NCT00729157Trial NCT00639509Trial NCT00601692Trial NCT00589472Trial NCT00570401Trial NCT00567229Trial NCT00550628Trial NCT00541034Trial NCT00528450Trial NCT00522301Trial NCT00521014Trial NCT00519974Trial NCT00514254Trial NCT00498927Trial NCT00483678Trial NCT00474994Trial NCT00471679Trial NCT00471601Trial NCT00470574Trial NCT00470470Trial NCT00462982Trial NCT00462501Trial NCT00459875Trial NCT00458705Trial NCT00453310Trial NCT00450827Trial NCT00416351Trial NCT00404365Trial NCT00398138Trial NCT00397904Trial NCT00369174Trial NCT00354679Trial NCT00334893Trial NCT00324480Trial NCT00245102Trial NCT00104845Trial NCT00090337Trial NCT00089245Trial NCT00087009Trial NCT00072345Trial NCT00072319Trial NCT00070057Trial NCT00067015Trial NCT00062374Trial NCT00059891Trial NCT00058253Trial NCT00054132Trial NCT00046917Trial NCT00040898Trial NCT00040872Trial NCT00039286Trial NCT00037011Trial NCT00036933Trial NCT00028730Trial NCT00024258Trial NCT00023764Trial NCT00020891Trial NCT00016146Trial NCT00014534Trial NCT00014469Trial NCT00008294Trial NCT00008242Trial NCT00006044Trial NCT00004245Trial NCT00004066Trial NCT00003923Trial NCT00003819Trial NCT00003173Trial NCT00003023Trial NCT00002981Trial NCT00002930Trial NCT00002766Trial NCT00002738Trial NCT00002718Trial NCT00002663Trial NCT00002558

Abstract

Description: The Clinical Research Program provides a coordinated focus for interdisciplinary, interdepartmental and interprogrammatic clinical research activities at MSKCC. It is organized into disease-oriented projects and treatment modality-related projects. The disease-oriented projects are programmatically linked with comprehensive Disease Management Teams. A Disease Management System has been implemented that includes 17 multidisciplinary teams, which allows for standardization of care, the collection of outcomes data, the capture of cost data, and the integration and refinement of the clinical research effort. The Disease Management System helps to prioritize and define the disease-specific research agenda of the Clinical Research Program. Though 65 project leaders are listed in the application, over 200 researchers and research fellows participate in this program. Disease-oriented projects include diagnostic and therapeutic activities in Brain Tumors, Breast Cancer, Gastrointestinal Cancer, Genitourinary Oncology, Gynecologic Oncology, Head and Neck Cancer, Hepatobiliary Cancer, Leukemia, Lymphoma, Melanoma, Multiple Myeloma, Musculoskeletal Cancers, Pediatric Oncology, Soft Tissue Sarcoma, and Thoracic Malignancies. Modality-related projects are organized in Conformal Radiation, Cytokines, Medical Imaging, Developmental Chemotherapy, Monoclonal Antibody Therapy and Cancer Vaccines, and Transplantation. There are many interactions among projects and programs. In 1995, there were 7212 new patients seen at MSKCC and 1959 accruals to protocols. A total of 59 new patients were placed on national protocols and 1084 patients on local studies. A total of 33 previously treated patients were placed on national studies and 783 patients on local studies. All of the core facilities play a fundamental role in the studies carried out within the Clinical Research Program and are essential to the ongoing research, especially Biostatistics for study design and data analysis. Funded peer-reviewed projects include 11 P01 grants, 8 U01 grants and a large number of R01 grants. In addition, there are 18 training grants and career development awards associated with the Clinical Research Program. External peer reviewed funding for research projects exceeded $18 million.

View original record on NIH RePORTER →